N-glycolylneuraminic acid serum biomarker levels are elevated in breast cancer patients at all stages of disease. Shewell LK, Day CJ, Kutasovic JR, Abrahams JL, et al. BMC Cancer 2022;22:334.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shewell LK, Day CJ, Kutasovic JR, Abrahams JL, et al. N-glycolylneuraminic acid serum biomarker levels are elevated in breast cancer patients at all stages of disease. BMC Cancer 2022;22:334.
PMID: 35346112